UBS lowered the firm’s price target on Exponent (EXPO) to $76 from $84 and keeps a Neutral rating on the shares.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXPO:
- Exponent’s Q2 2025 Earnings: Steady Revenue Amid Challenges
- Exponent Declares Quarterly Dividend Amid Revenue Growth
- Exponent reports Q2 EPS (52c), consensus 52c
- Exponent sees Q3 revenue before reimbursements up mid-single digits
- Exponent sees FY25 revenue before reimbursements up in the low single digits